Neko Health Raises $700 Million For US AI Body-Scan Clinics
AI News reported that Neko Health raised $700 million to expand AI body-scan clinics in the United States, starting with New York. The source cited FDA 510(k) clearances for two Neko devices; U.S. pricing, additional clinic locations, false-positive rates and completed peer-reviewed validation for the full screening service remain outside the public record.
$700 million in new Series C funding will take Neko Health's AI body-scan clinic model into the United States, starting with New York, AI News reported.
The preventive-screening company combines medical imaging, blood tests, proprietary sensors and clinician review in a clinic visit built around early health-risk detection.
Lightspeed Venture Partners led the round and O.G. Venture Partners co-led it.
Atomico, General Catalyst and Lakestar returned as investors.
Liberty City Ventures, Positive Sum and BDT & MSD joined as new backers.
Funding Brings Disclosed Capital Above $1 Billion
The new round brings Neko Health's disclosed capital raised since 2023 to more than $1 billion.
Earlier fundraising included a $65 million Series A in 2023 and a $260 million round in January 2025.
David Ofer of O.G. Venture Partners is expected to join the board, subject to regulatory approval.
The financing also included investments from Mark Zuckerberg and Priscilla Chan, Maria Sharapova, will.i.am and Thierry Henry.
Existing individual investors include Alexis Ohanian and Zoë Saldaña.
The funding is intended to support clinics in New York and other U.S. cities.
A New York waitlist is open, but additional U.S. locations and the detailed rollout schedule remain outside the cited public materials.
Neko Health Scan Combines Imaging, Blood Tests And Clinician Review
Neko Health's clinics use body-scan hardware, blood testing, AI analysis and custom medical equipment.
The service screens customers for potential signs of skin cancer, cardiovascular disease and diabetes.
Neko Health describes the assessment as a 60-minute, non-invasive and radiation-free visit.
Its materials say the visit includes an electrocardiogram, arterial measurements, body-composition analysis and more than 2,000 high-resolution skin images, with blood samples processed at the clinic so results can be reviewed during the same visit.
Results are discussed in person with a medical professional.
Specialist clinicians, including dermatologists and cardiologists, review findings that require further examination, and the privacy notice tells customers to continue seeing their existing clinicians for diagnosis and treatment.
Existing Clinics Give Pricing And Usage Evidence
The company currently operates eight clinics across the UK and Sweden.
The clinic list includes two sites in Stockholm, one each in Manchester and Birmingham, and four London locations in Marylebone, Spitalfields, Covent Garden and Victoria.
The listed prices are £299 in the UK and 2,750 Swedish kronor in Sweden.
Neko Health reports completing 100,000 scans since launching the service in 2023, while more than 350,000 people have registered for a scan or joined waitlists.
Three quarters of customers reserve and prepay for a follow-up scan before leaving the appointment.
That repeat-booking figure is important for the business model because preventive clinics need recurring demand, not only one-time curiosity around a new health technology.
The U.S. expansion will test whether the European clinic economics, patient demand and clinician-review workflow can travel into a more complex healthcare market.
Neko Health has not disclosed New York pricing, U.S. insurance arrangements, clinical outcome data or the number of U.S. clinics planned after the first opening.
